CLSI EP26

User Evaluation of Between-Reagent Lot Variation; Approved Guideline, EP26Ed2E

Clinical and Laboratory Standards Institute, 04/01/2022

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/04/2022

Pages:122

File Size:1 file , 9 MB

Note:This product is unavailable in Russia, Belarus

This guideline includes recommendations for laboratories on evaluating a new reagent lot, based on a protocol that uses patient samples to detect clinically important changes from the current lot.

More CLSI standard pdf

CLSI QMS07-A2

CLSI QMS07-A2

Application of a Quality Management System Model for Respiratory Services; Approved Guideline, QMS07A2E

$140.00 $280.89

CLSI I/LA02-A2

CLSI I/LA02-A2

Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods; Approved Guideline, I/LA02A2E

$123.00 $247.71

CLSI GP02A5

CLSI GP02A5

Clinical Laboratory Technical Procedure Manuals; Approved Guideline, GP02-A5

$135.00 $271.52

CLSI AUTO09-A

CLSI AUTO09-A

Remote Access to Clinical Laboratory Diagnostic Devices via the Internet; Approved Standard, AUTO09AE

$136.00 $273.14